Alkali-urea extraction of demineralized bone matrix removes noggin, an inhibitor of bone morphogenetic proteins

Connective Tissue Research

Volumn 45, Issue 4-5, 2004, Pages 257-260

  Behnam, Keyvan ^a,b   Brochmann, Elsa J ^a,c   Murray, Samuel S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Osteotech Inc   (United States)

^c Sepulveda Ambulatory Care Center   (United States)

Author keywords

Bone; Bone morphogenetic proteins; Noggin; Osteogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NOGGIN;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; EXTRACTION; METHODOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; OSSIFICATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ALKALIES; ANIMALS; BONE DEMINERALIZATION TECHNIQUE; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CATTLE; HYDROXIDES; MALE; MICE; MICE, NUDE; OSTEOGENESIS; POTASSIUM COMPOUNDS; PROTEINS; TISSUE EXTRACTS; UREA;

EID: 12344329197     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200490903048     Document Type: Article

References (21)

1. Urist, M.R. (1965). Bone: Formation by autoinduction. Science 150:893-899.
2. Reddi, A.H., and Huggins, C. (1972). Biochemical sequeuces in the transformation of normal fibroblasts in adolescent rats. Proc. Natl. Acad. Sci. USA 69:1601-31605.
3. Urist, M.R., Huo, Y.K., Brownell, A.G., Hohl, W.M., Buyske, J., Lietze, A., Tempst, P., Hunkapiller, M., and DeLange, R.J. (1984). Purification of bovine bone morphogenctic protein by hydroxyapatite chromatography. Proc. Natl. Acad. Sci. USA 81:371-375.
4. Urist, M.R. (1991). Emerging concepts of bone morphogenetic protein. In Fundamentals of Bone Growth: Methodology and Applications A.D. Dixon. B.G. Sarnat, and D.A.N. Hoyte (eds.), pp. 189-198. Boston: C.R.C. Press.
5. Smith, W.C., Knecht, A.K., Wu, M., and Harland, R.M. (1993). Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature 361:547-549.
6. Reddi, A.H. (2001). Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: Noggin, chordin and DAN. Arthritis Res. 3:1-5.
7. Zimmerman, L.B., De Jesus-Escobar, J.M., and Harland, R.M. (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606.
8. Lamb, T.M., Knecht, A.K., Smith, W.C., Stachel, S.E., Economides, A.N., Stahl, N., Yancopolous, G.D., and Harland, R.M. (1993). Neural induction by the secreted polypeptide noggin. Science 262:713-718.
9. Dale, L., Howes, G., Price. B.M., and Smith, J.C. (1992). Bone morphogenetic protein 4: A ventralizing factor in early Xenopus development. Development 115:573-585.
10. Jones, C.M., Lyons, K.M., Lapan, P.M., Wright, C.V., and Hogan, B.L. (1992). DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development 115:639-647.
11. Wilson, P.A., and Hemmati-Brivanlou, A. (1995). Induction of epidermis and inhibition of neural fate by BMP 4. Nature 376:331-333.
12. Groppe, J., Greenwald, J., Wiater, E., Rodriguez-Leon, J., Economides, A., Kwiatkowski, W., Affolter, M., Vale, W., Belmonte, J., and Choe, S. (2002). Structural basis of BMP signaling inhibition by the cystein knot protein noggin. Nature 420:636-642.
13. Brunet, L.J., McMahon, J.A., McMahon, A.P., and Harland, R.A. (1998). Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280:1455-1457.
14. Devlin, R.D., Du, Z., Pereira, R.C., Kimble, R.B., Economides, A.N., Jorgetti, V., and Canalis, E. (2003). Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144:1972-1978.
15. Nakamura, Y., Wakitani, S., Nakayama, J., Wakabayashi, S., Horiuchi, H., and Takaoka, K. (2003). Temporal and spatial expression profiles of BMP receptors and noggin during bmp-2-induced ectopic bone formation. J. Bone Min. Res. 18:1854-1862.
16. Stottmann, R.W., Anderson, R.M., and Klingensmith, J. (2001). The BMP antagonists chordin and noggin have essential but red undant roles in mouse mandibular outgrowth. Dev. Biol. 240:457-473.
17. Theis, R.S., Bauduy, M., Ashton, B.A., Kurtzberg, L., Wozney, J.M., and Rosen, V. (1992). Recombinant human bone morphogenetic protem-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324.
18. Semonin, O., Fontaine, K., Daviaud, C., Ayuso, C., and Lucotte, G. (2001). Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am. J. Med. Genet. 102:314-317.
19. Gong, Y., Krakow, D., Marcelino, J., Wilkin, D., Chitayat, D., Babul-Hirji, R., Hudgins, L., Cremers, C.W., Cremers, F.P., Brunner, H.G., Reinker, K., Rimoin, D.L., Cohen, D.H., Goodman, F.R., Reardon, W., Patton, M., Francomano, C.A., and Warman, M.L. (1999). Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nature Genet. 21:302-304.
20. Aspenberg, P., Jeppsson, C., and Economides, A.N. (2001). The bone morphogenetic proteins antagonist noggin inhibits membranous ossification. J. Bone Mineral Res. 16:497-500.
21. Hannallah, D., Peng, H., Young, B., Usas, A., Gearhart, B., and Huard, J. (2004). Retroviral delivery of noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J. Bone Joint Surg. 86:80-91.